Breaking News Instant updates and real-time market news.

ABMD

Abiomed

$283.88

7.48 (2.71%)

09:25
03/29/19
03/29
09:25
03/29/19
09:25

Abiomed participates in a conference call with Morgan Stanley

Medical Devices Analyst Lewis holds a conference call with Chairman, President & CEO Minogue on March 29 at 10 am hosted by Morgan Stanley.

  • 29

    Mar

ABMD Abiomed
$283.88

7.48 (2.71%)

03/25/19
PIPR
03/25/19
NO CHANGE
PIPR
Piper sees six 'quality' Med Tech names whose stocks haven't rallied
Medical Technology stocks have rebounded quickly in Q1 following a challenging Q4 of 2018 as the combination of solid year-end results and compelling outlooks for next year have led investors back into the names, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst, however, has identified six "quality" names that have not participated in the Q1 share appreciation, "despite consistently delivering beat-and-raises." The basket of stocks include Abiomed (ABMD), Merit Medical (MMSI), AtriCure (ATRC), Neuronetics (STIM), SeaSpine (SPNE) and Nuvectra (NVTR).
02/05/19
WBLR
02/05/19
NO CHANGE
WBLR
Outperform
FDA letter adds 'question mark' to Abiomed story, says William Blair
The "Dear Doctor" letter, notifying clinicians of interim results from its post-approval study on Impella RP, "adds a question mark" to the Abiomed story, William Blair analyst Margaret Kaczor tells investors in a research note. However, from a fundamental perspective, Impella RP has been a relatively small part of Abiomed's revenues, contributing approximately $6.6M in its fiscal Q3. Thus, the analyst believes Abiomed can continue to grow over 20% over the next several years without significant contribution from Impella RP. Kaczor keeps an Outperform rating on Abiomed.
02/05/19
JEFF
02/05/19
NO CHANGE
Target $460
JEFF
Buy
Abiomed selloff on FDA letter to doctors overblown, says Jefferies
The selloff in shares of Abiomed after FDA notified doctors of higher mortality in the post approval study of Impella RP is overblown, Jefferies analyst Raj Denhoy tells investors in a research note. Sales of RP were 4% of sales in the most recent quarter at Abiomed, the analyst points out. Further, he sees "little risk" as the company "stresses timely and appropriate use of the pump." While there might be "some minor hiccup in sales to the tune of 1%-2%," there shouldn't be any lasting impact to the prospects of the RP pump, says Denhoy. Further, he believes the letter could have a "silver lining" as there is now evidence that the pump should be used sooner and patients not allowed to decompensation so dramatically before implantation. The analyst sees no impact to Abiomed's total addressable market and says the company remains the "best growth story in medtech." He keeps a Buy rating on the shares with a $460 price target.
02/04/19
PIPR
02/04/19
NO CHANGE
Target $480
PIPR
Overweight
Piper Jaffray expects impact on Abiomed from FDA letter to be minimal
Piper Jaffray analyst Matt O'Brien kept his Overweight rating and $480 price target on Abmiomed, saying there are nuances to the recent issuance of a "Dear Doctor" letter related to the Impella RP. The analyst notes that 16 of the 23 patients enrolled in the PAS "would not have met the enrollment criteria for the premarket study", so the survival in patients on protocal would have been higher than the 17% reported at 43% or 57%. O'Brien expects the impact of the letter to be minimal to RP utilization, stating that the opportunity for the program "remains healthy".

TODAY'S FREE FLY STORIES

LTXB

LegacyTexas Financial

$39.02

0.11 (0.28%)

18:36
06/18/19
06/18
18:36
06/18/19
18:36
Downgrade
LegacyTexas Financial rating change  »

LegacyTexas Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

UNP

Union Pacific

$165.49

0.885 (0.54%)

18:24
06/18/19
06/18
18:24
06/18/19
18:24
Hot Stocks
Union Pacific CEO: The President is addressing the right topics with China »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

MYOS

MYOS

$1.40

0.11 (8.53%)

18:12
06/18/19
06/18
18:12
06/18/19
18:12
Hot Stocks
MYOS says fortetropin shows increase rate of muscle protein synthesis in study »

MYOS RENS Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.71

0.58 (1.61%)

18:06
06/18/19
06/18
18:06
06/18/19
18:06
Periodicals
Breaking Periodicals news story on General Motors »

GM, UAW negotiating to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 12

    Aug

BXC

BlueLinx

$22.03

0.305 (1.40%)

18:00
06/18/19
06/18
18:00
06/18/19
18:00
Hot Stocks
BlueLinx sells two distribution facilities for $12M »

BlueLinx Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, BA

Boeing

$374.21

19.31 (5.44%)

17:59
06/18/19
06/18
17:59
06/18/19
17:59
Periodicals
U.S. expected to be open to ending aircraft subsidy dispute, Reuters says »

The U.S. is expected to…

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$374.21

19.31 (5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

FB

Facebook

$188.46

-0.43 (-0.23%)

17:56
06/18/19
06/18
17:56
06/18/19
17:56
Periodicals
House Banking chair Waters calls on Facebook to halt Libra, Reuters says »

House Financial Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

OII

Oceaneering

$18.34

0.7 (3.97%)

, APC

Anadarko

$69.95

0.16 (0.23%)

17:36
06/18/19
06/18
17:36
06/18/19
17:36
Hot Stocks
Oceaneering awarded supply contract for Mozambique LNG Project »

Oceaneering (OII)…

OII

Oceaneering

$18.34

0.7 (3.97%)

APC

Anadarko

$69.95

0.16 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

GVA

Granite Construction

$44.64

1.335 (3.08%)

17:35
06/18/19
06/18
17:35
06/18/19
17:35
Hot Stocks
Granite Construction JV awarded $275M highway construction project in Sacremento »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$69.95

0.16 (0.23%)

, FTI

TechnipFMC

$23.76

0.7 (3.04%)

17:33
06/18/19
06/18
17:33
06/18/19
17:33
Hot Stocks
TechnipFMC awarded subsea contracts by subsidiary of Anadarko Petroleum »

TechnipFMC (FTI) has been…

APC

Anadarko

$69.95

0.16 (0.23%)

FTI

TechnipFMC

$23.76

0.7 (3.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 25

    Jul

MDT

Medtronic

$97.96

0.65 (0.67%)

17:33
06/18/19
06/18
17:33
06/18/19
17:33
Hot Stocks
Medtronic exec Surface sells 9,000 ordinary shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

EAF

GrafTech

$10.95

0.14 (1.30%)

17:20
06/18/19
06/18
17:20
06/18/19
17:20
Syndicate
Breaking Syndicate news story on GrafTech »

GrafTech files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$69.95

0.16 (0.23%)

17:12
06/18/19
06/18
17:12
06/18/19
17:12
Hot Stocks
Anadarko Area 1 Plan of Development now effective »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMASY

Inmarsat

$0.00

(0.00%)

17:11
06/18/19
06/18
17:11
06/18/19
17:11
Hot Stocks
Inmarsat awarded $246M Defense Information Systems Agency BPA »

Inmarsat has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$41.32

-0.505 (-1.21%)

17:03
06/18/19
06/18
17:03
06/18/19
17:03
Hot Stocks
Deluxe appoints Chief Strategy Officer, Chief Human Resources Officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFIE

Profire Energy

$1.40

0.03 (2.19%)

17:02
06/18/19
06/18
17:02
06/18/19
17:02
Hot Stocks
Profire Energy subsidiary to acquire assets of Millstream Energy Products »

Profire Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$14.59

0.29 (2.03%)

, GOOG

Alphabet

$1,104.40

12.15 (1.11%)

17:02
06/18/19
06/18
17:02
06/18/19
17:02
Hot Stocks
HP Enterprise, Google Cloud expand strategic partnership »

HP Enterprise (HPE) and…

HPE

HP Enterprise

$14.59

0.29 (2.03%)

GOOG

Alphabet

$1,104.40

12.15 (1.11%)

GOOGL

Alphabet Class A

$1,105.22

12.51 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

HPE

HP Enterprise

$14.59

0.29 (2.03%)

17:01
06/18/19
06/18
17:01
06/18/19
17:01
Hot Stocks
HP Enterprise to transition into an as a Service company by 2022 »

Hewlett Packard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:55
06/18/19
06/18
16:55
06/18/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Macom »

Macom falls 13% to $12.50…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:53
06/18/19
06/18
16:53
06/18/19
16:53
Hot Stocks
Macom to lay off 20% of staff or 250 workers, expects $50M in savings »

MACOM announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRK

Scholar Rock

$19.95

1.265 (6.77%)

16:52
06/18/19
06/18
16:52
06/18/19
16:52
Syndicate
Scholar Rock files to sell 3M shares of common stock »

Jefferies, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:50
06/18/19
06/18
16:50
06/18/19
16:50
Earnings
Macom cuts Q3 EPS view to (45c) to (41c) from (8c) to (4c), consensus (6c) »

Cuts Q3 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTSI

Macom

$14.40

-0.02 (-0.14%)

16:48
06/18/19
06/18
16:48
06/18/19
16:48
Earnings
Breaking Earnings news story on Macom »

Macom cuts Q3 EPS,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTFT

Future FinTech

$1.18

0.04 (3.51%)

16:48
06/18/19
06/18
16:48
06/18/19
16:48
Hot Stocks
Future FinTech submits compliance plan to Nasdaq »

Future FinTech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKOH

Park-Ohio

$32.11

-0.08 (-0.25%)

16:45
06/18/19
06/18
16:45
06/18/19
16:45
Hot Stocks
ParkOhio's Edward Crawford resigns as officer, board member »

ParkOhio announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.